Literature DB >> 2687068

Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines.

S D Wolpe1, A Cerami.   

Abstract

A number of studies of inflammation and of cell growth and transformation have recently converged by defining two related families of cytokines. The first, represented by macrophage inflammatory protein 1, is composed of several gene products that have been identified in activated T cells, macrophages, and fibroblasts. The biological activities of this family are still being characterized but so far include effects on neutrophils, monocytes, and hematopoietic cells. The second, represented by macrophage inflammatory protein 2, includes platelet products such as platelet factor 4 and beta-thromboglobulin as well as several other recently described gene products that have effects on a number of cell types including neutrophils, fibroblasts, hematopoietic cells, and melanoma cells. The two families are structurally related and may have evolved from a common ancestral gene that duplicated and then diverged. Their differential control and expression in a wide variety of cell types suggests that they may have multiple functions in regulating inflammation and cell growth.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2687068     DOI: 10.1096/fasebj.3.14.2687068

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  117 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

2.  Evidence of CXC, CC and C chemokine production by lymphatic endothelial cells.

Authors:  Sabrina Mancardi; Elena Vecile; Nelson Dusetti; Ezequiel Calvo; Giorgio Stanta; Oscar R Burrone; Aldo Dobrina
Journal:  Immunology       Date:  2003-04       Impact factor: 7.397

3.  Neutralization of macrophage inflammatory protein 2 (MIP-2) and MIP-1alpha attenuates neutrophil recruitment in the central nervous system during experimental bacterial meningitis.

Authors:  A Diab; H Abdalla; H L Li; F D Shi; J Zhu; B Höjberg; L Lindquist; B Wretlind; M Bakhiet; H Link
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

4.  Macrophage inflammatory protein 1 alpha expression by synovial fluid neutrophils in rheumatoid arthritis.

Authors:  Y Hatano; T Kasama; H Iwabuchi; R Hanaoka; H T Takeuchi; L Jing; Y Mori; K Kobayashi; M Negishi; H Ide; M Adachi
Journal:  Ann Rheum Dis       Date:  1999-05       Impact factor: 19.103

5.  C5a-regulated CCAAT/enhancer-binding proteins β and δ are essential in Fcγ receptor-mediated inflammatory cytokine and chemokine production in macrophages.

Authors:  Chunguang Yan; Mei Zhu; Jennifer Staiger; Peter F Johnson; Hongwei Gao
Journal:  J Biol Chem       Date:  2011-12-06       Impact factor: 5.157

6.  CD44 deficiency leads to enhanced neutrophil migration and lung injury in Escherichia coli pneumonia in mice.

Authors:  Qin Wang; Priit Teder; Nancy P Judd; Paul W Noble; Claire M Doerschuk
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

7.  Epithelins 1 and 2: isolation and characterization of two cysteine-rich growth-modulating proteins.

Authors:  M Shoyab; V L McDonald; C Byles; G J Todaro; G D Plowman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

8.  Differential anti-inflammatory and anti-oxidative effects of dexamethasone and N-acetylcysteine in endotoxin-induced lung inflammation.

Authors:  D Rocksén; B Lilliehöök; R Larsson; T Johansson; A Bucht
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

Review 9.  Exercise and the immune system. Natural killer cells, interleukins and related responses.

Authors:  R J Shephard; S Rhind; P N Shek
Journal:  Sports Med       Date:  1994-11       Impact factor: 11.136

10.  Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice.

Authors:  Laurent Yvan-Charvet; Mollie Ranalletta; Nan Wang; Seongah Han; Naoki Terasaka; Rong Li; Carrie Welch; Alan R Tall
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.